Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 02 Jan 2026 for Janux Therapeutics, Inc., €17k. Read the official filing
Filing timeline
BuySaleMaria Dobek
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Maria Dobek: trading record in brief
This profile gathers the share dealings of Maria Dobek in Janux Therapeutics, Inc. Between 2 January 2025 and 2 January 2026, the trades on record add up to 2 filings.
Sales make up the whole of the open-market record (1 sale, €17k). Outside the open market, there are 1 share grant. So far in 2026, the count stands at no purchases and 1 sale.
On 2 January 2026 came the latest disclosure, an open-market sale for €17k in Janux Therapeutics, Inc. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Maria Dobek
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,462 shares@ US$13.73Common StockSEC:0002032671-26-000002:0
14,000 shares0Common StockSEC:0001415889-25-000672:0
2 of 2 declarations
